The current landscape of pain management is shifting. There’s a huge reaction to opioids and the negative impact they’ve had on many people’s lives. Alongside that, there’s a rise in the interest in cannabinoids. Might the legalization of marijuana ultimately reduce opioid deaths? How can pain practitioners deal with the onslaught of contradictory information? Dr. Charles Argoff, Senior PAINWeek faculty, offers his views.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox